Takara Bio (Germany) Market Outlook
| TF2 Stock | EUR 5.00 0.40 7.41% |
Roughly 60% of Takara Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Takara Bio suggests that many traders are alarmed. The current market sentiment, together with Takara Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Takara Bio stock news signals to limit their universe of possible portfolio assets.
Comfort Level 40
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Takara Bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Takara Bio.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Takara Bio is 'Strong Sell'. Macroaxis provides Takara Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TF2 positions.
Execute Takara Bio Advice
The Takara recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Takara Bio. Macroaxis does not own or have any residual interests in Takara Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Takara Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Fair | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Fair | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon Takara Bio has a Mean Deviation of 2.05, Semi Deviation of 2.55, Standard Deviation of 4.09, Variance of 16.69, Downside Variance of 8.41 and Semi Variance of 6.48We provide advice to complement the current expert consensus on Takara Bio. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Takara Bio is not overpriced, please validate all Takara Bio fundamentals, including its price to book, revenue, and the relationship between the price to earning and price to sales .
Takara Bio Trading Alerts and Improvement Suggestions
| Takara Bio had very high historical volatility over the last 90 days | |
| Takara Bio has high likelihood to experience some financial distress in the next 2 years | |
| About 62.0% of the company outstanding shares are owned by corporate insiders |
Takara Bio Returns Distribution Density
The distribution of Takara Bio's historical returns is an attempt to chart the uncertainty of Takara Bio's future price movements. The chart of the probability distribution of Takara Bio daily returns describes the distribution of returns around its average expected value. We use Takara Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Takara Bio returns is essential to provide solid investment analysis for Takara Bio.
| Mean Return | 0.16 | Value At Risk | -3.32 | Potential Upside | 4.19 | Standard Deviation | 4.09 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Takara Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Takara Bio Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change To Inventory | (14.2B) | 13.5B | (324M) | 102M | 117.3M | 123.2M | |
| Investments | 1.5B | (6.7B) | 713M | (94M) | (108.1M) | (102.7M) | |
| Change In Cash | (1.1B) | 26.9B | (15.9B) | (6.1B) | (5.5B) | (5.2B) | |
| Depreciation | 4.1B | 4.7B | 5.0B | 4.5B | 5.2B | 3.6B | |
| Dividends Paid | 1.9B | 4.0B | (5.1B) | (2.0B) | (1.8B) | (1.8B) | |
| Capital Expenditures | 12.4B | 5.7B | 12.9B | 10.3B | 11.8B | 6.9B | |
| Net Income | 18.5B | 16.0B | 1.5B | 1.0B | 1.2B | 1.1B | |
| Change To Netincome | (338M) | (1.6B) | (4.9B) | (9.1B) | (8.2B) | (7.8B) | |
| End Period Cash Flow | 22.2B | 49.1B | 33.2B | 27.0B | 31.1B | 23.8B | |
| Free Cash Flow | (5.6B) | 31.0B | (11.2B) | (4.4B) | (4.0B) | (3.8B) | |
| Other Non Cash Items | (625M) | (634M) | (277M) | (284M) | (255.6M) | (268.4M) |
Takara Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Takara Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Takara Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Takara stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | -0.82 | |
σ | Overall volatility | 4.09 | |
Ir | Information ratio | 0.02 |
Takara Bio Volatility Alert
Takara Bio currently demonstrates below-average downside deviation. It has Information Ratio of 0.02 and Jensen Alpha of 0.2. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Takara Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Takara Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Takara Bio Fundamentals Vs Peers
Comparing Takara Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Takara Bio's direct or indirect competition across all of the common fundamentals between Takara Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Takara Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Takara Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Takara Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Takara Bio to competition |
| Fundamentals | Takara Bio | Peer Average |
| Return On Equity | -0.068 | -0.31 |
| Return On Asset | -0.0053 | -0.14 |
| Profit Margin | (0.16) % | (1.27) % |
| Operating Margin | (0.26) % | (5.51) % |
| Current Valuation | 470.83 M | 16.62 B |
| Shares Outstanding | 120.42 M | 571.82 M |
| Shares Owned By Insiders | 61.73 % | 10.09 % |
| Shares Owned By Institutions | 7.23 % | 39.21 % |
| Price To Earning | 52.31 X | 28.72 X |
| Price To Book | 1.15 X | 9.51 X |
| Price To Sales | 0.01 X | 11.42 X |
| Revenue | 45.04 B | 9.43 B |
| Gross Profit | 23.84 B | 27.38 B |
| EBITDA | 3.98 B | 3.9 B |
| Net Income | 1.04 B | 570.98 M |
| Cash And Equivalents | 31.49 B | 2.7 B |
| Cash Per Share | 261.48 X | 5.01 X |
| Total Debt | 9.49 B | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 3.30 X | 2.16 X |
| Book Value Per Share | 4.63 X | 1.93 K |
| Cash Flow From Operations | 5.84 B | 971.22 M |
| Earnings Per Share | (0.29) X | 3.12 X |
| Number Of Employees | 1.78 K | 18.84 K |
| Beta | 0.37 | -0.15 |
| Market Capitalization | 650.71 M | 19.03 B |
| Total Asset | 125.33 B | 29.47 B |
| Retained Earnings | 52.47 B | 9.33 B |
| Working Capital | 50.55 B | 1.48 B |
| Annual Yield | 0.02 % | |
| Five Year Return | 0.25 % | |
| Net Asset | 125.33 B | |
| Last Dividend Paid | 17.0 |
Takara Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Takara . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Takara Bio Buy or Sell Advice
When is the right time to buy or sell Takara Bio? Buying financial instruments such as Takara Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Takara Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals Funds Thematic Idea Now
Precious Metals Funds
Funds or Etfs that invest in entities that are involved in mining, processing or dealing of precious metals. The Precious Metals Funds theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Takara Stock
Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.